Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04225442 · ClinicalTrials.gov registry record · NA
The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions
A NA study of Healthy and Healthy Aging, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT04225442: Active NA study of Healthy and Healthy Aging, sponsored by University of Pennsylvania.
NCT04225442 is a NA study of Healthy and Healthy Aging that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 48 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04225442, a NA study of Healthy and Healthy Aging, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators piloted the characterization of the human chronobiome. Now, this line of research is extended to explore physiological chronobiome modulated by sex, age and under evoked conditions.
Primary Outcome
High-throughput proteomics analysis determines the number of proteins with and without post-translational modifications. This will explore what effect age has on the number of proteins with post-translational modifications.
Conditions Studied
Interventions
- OTHER Fatty meal to challenge the physiological chronobiome in healthy young and old
Study Locations (1)
Pennsylvania
- Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2020-01-05 |
| Est. Completion | 2028-06-04 |
| Phase | NA |
What the registry record for NCT04225442 still lists
NCT04225442 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Fatty meal to challenge the physiological chronobiome in healthy young and old is the first listed.
NCT04225442 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04225442 about?
NCT04225442 is a clinical study titled "The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions". The investigators piloted the characterization of the human chronobiome. Now, this line of research is extended to explore physiological chronobiome modulated by sex, age and under evoked conditions.
What is the current status of trial NCT04225442?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2020-01-05. Estimated completion is 2028-06-04.
What conditions does trial NCT04225442 study?
This clinical trial studies the following conditions: Healthy, Healthy Aging.
What interventions are being tested in trial NCT04225442?
The interventions under investigation include: Fatty meal to challenge the physiological chronobiome in healthy young and old (OTHER).
Who is sponsoring clinical trial NCT04225442?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04225442 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04225442's enrollment target sits among peer trials
48 479th of 1090 higher than 602 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI